
The American Society for Radiation Oncology (ASTRO) published updated clinical guidelines on August 13, 2026, providing evidence-based recommendations for using radiation therapy to treat adult pancreatic cancer patients.
With an estimated 67,500 U.S. adults expected to be diagnosed with pancreatic cancer in 2026, the guidelines emphasize multidisciplinary care to improve local control and surgical outcomes.
The updated recommendations clarify the role of preoperative and postoperative chemoradiation for resectable and locally advanced cases, reflecting new clinical evidence and technological advances in image-guided radiation delivery.